¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"compound event"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°
  • closed-chain compound
    ´ÝÈù»ç½½È­ÇÕ¹°
  • complex compound
    º¹ÇÕÈ­ÇÕ¹°
  • compound
    1. È­ÇÕ¹° 2. º¹ÇÕ
  • compound astigmatism
    º¹ÇÕ³­½Ã
  • compound dislocation
    º¹ÀâÅ»±¸
  • compound fracture
    º¹ÇÕ°ñÀý, °³¹æ°ñÀý
  • compound gland
    º¹ÇÕ»ù, º¹ÇÕ¼±
  • compound heterozygote
    º¹ÇÕÀÌÇüÁ¢ÇÕÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • compound
    º¹Àâ, º¹ÇÕ, È­ÇÕ¹°
  • organic compound
    À¯±âÈ­ÇÕ¹°
  • compound nevus
    º¹ÇÕ¸ð¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°
  • compound astigmatism
    º¹ÇÕ³­½Ã
  • compound
    º¹Àâ, º¹ÇÕ, È­ÇÕ¹°
  • chain compound
    »ç½½È­ÇÕ¹°
  • complex compound
    º¹ÇÕÈ­ÇÕ¹°
  • compound dislocation
    º¹ÀâÅ»±¸
  • compound fracture
    º¹Àâ°ñÀý, °³¹æ°ñÀý
  • compound gland
    º¹ÇÕ»ù
  • compound joint
    º¹ÇÕ°üÀý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SRE, Schedule of Recent Event
    ÃÖ±Ù»ç°Ç¿¡ ´ëÇÑ ¸ñ·Ï
  • adverse event
    À¯ÇØ»ç·Ê(êóúªÞÀçÓ).
  • independent event
    µ¶¸³»ç»ó(ËÄËöË×Ë×).
  • acyclic compound
    ºñȯ»óÈ­ÇÕ¹°.
  • addition compound
    ÷°¡È­ÇÕ¹°(ôÕÊ¥ ûùùêÚª).
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°.
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°.
  • amino compound
    ¾Æ¹Ì³ëÈ­ÇÕ¹°(¡­ûùùêÚª).
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°(¡­ûùùêÚª).
  • antimuscarinic compound
    Ç×¹«½ºÄ«¸°Á¦.
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°.
  • heme compound
    ÇðÈ­ÇÕ¹°
  • heterocyclic compound
    ÇìÅ×·Î°í¸®È­ÇÕ¹°, ÀÌÁ¾¿øÀÚ°í¸®È­ÇÕ¹°.
  • heteropolar compound
    ÀÌ(¼º)±ØÈ­ÇÕ¹°(ì¶àõпûùùêÚª).
  • homeopolar compound
    µ¿±ØÈ­ÇÕ¹°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • compound event
    º´ÀÇ º¹ÇÕ»ç°Ç(ËÓ̰Ë×˧).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adverse event
    À¯ÇØ»ç·Ê(êóúªÞÀçÓ).
  • cardiac event
    ½É(Àå)»ç°Ç(ãýíõÞÀËì)
  • energy deposition event
    ¿¡³ÊÁöºÎ¿©Çö»ó
  • event
    »ç°Ç(Ë×˧).
  • event-related potential
    »ç°Ç°ü·ÃÀüÀ§(ÞÀËìμ֤ï³êÈ)
  • independent event
    µ¶¸³»ç»ó(ËÄËöË×Ë×).
  • acyclic compound
    ºñȯ»óÈ­ÇÕ¹°.
  • addition compound
    ÷°¡È­ÇÕ¹°(ôÕÊ¥ ûùùêÚª).
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°.
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°.
  • amino compound
    ¾Æ¹Ì³ëÈ­ÇÕ¹°(¡­ûùùêÚª).
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°(¡­ûùùêÚª).
  • antimuscarinic compound
    Ç×¹«½ºÄ«¸°Á¦.
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°.
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Compound gland
    º¹ÇÕ»ù
    [¿¾ ¿ë¾î] º¹ÇÕ¼±
  • Compound intercellular junction
    º¹ÇÕ¼¼Æ÷»çÀÌ¿¬Á¢
    [¿¾ ¿ë¾î] º¹ÇÕ¼¼Æ÷°£°áÇÕ[¿¬Á¢]
  • Compound intercellular junction
    º¹ÇÕ¼¼Æ÷»çÀÌ¿¬Á¢
    [¿¾ ¿ë¾î] º¹ÇÕ¼¼Æ÷¿¬Á¢
  • Compound joint
    º¹ÇÕ°üÀý
    [¿¾ ¿ë¾î] º¹°üÀý
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbamate compound
    Ä«¹Ù¸ÞÀÌÆ®°è »ìÃæÁ¦
  • chlorinated hydrocarbon compound
    À¯±â¿°¼Ò°è»ìÃæÁ¦
  • organophosphorus compound
    À¯±âÀΰè»ìÃæÁ¦
  • pyrethroid compound
    ÇÇ·¹½º·ÎÀ̵å°è»ìÃæÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alicyclic compound
    ºñ(Þª)°í¸®Çü(û¡)È­ÇÕ¹°(ûùùêÚª)
  • anticancer compound
    Ç×¾ÏÈ­ÇÕ¹°(ù÷äßûùùêÚª)
  • antithyroid compound
    Ç×°©»ó¼± È­ÇÕ¹°(ù÷Ë£ßÒàÍûùùêÚª)
  • azo compound
    ¾ÆÁ¶È­ÇÕ¹°(ûùùêÚª)
  • carbamino compound
    Ä«¸£¹Ù¸¶À̵å È­ÇÕ¹°(ûùùêÚª)
  • compound
    È­ÇÕ¹°(ûùùêÚª)
  • compound lipid
    "È­ÇÕÁöÁú(ûùùêò·òõ), (ÔÒ) complex lipid"
  • compound microscope
    º¹ÇÕÇö¹Ì°æ(ÜÜùêúéÚ°Ìð)
  • diazo compound
    µð¾ÆÁ¶ È­ÇÕ¹°(ûùùêÚª)
  • diazonium compound
    µð¾ÆÁ¶´½ È­ÇÕ¹°(ûùùêÚª) (ÔÒ) diazonium salt
  • energy-poor compound
    ºó(Þ¸)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • energy-rich compound
    ºÎ(Ý£)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • enzyme-substrate compound
    È¿¼Ò-±âÁú È­ÇÕ¹° (ý£áÈÐñòõûùùêÚª)
  • high-energy compound
    °í(ÍÔ)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • Kendall's compound
    ÄË´Þ È­ÇÕ¹°(ûùùêÚª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • compound
    È­ÇÕ¹°, ÄÄÆÄ¿îµå
  • compound scan
    º¹ÇÕ½ºÄµ
  • compound scan motion
    º¹ÇÕ½ºÄµ¿îµ¿
  • compound sector
    º¹ÇÕ ºÎä²Ã
  • contact compound scan
    Á¢Ã˺¹ÇÕ½ºÄµ
  • inorganic compound
    ¹«±âÈ­ÇÕ¹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PCC Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl...
ALTE Apparent Life-Threatening Event; »ý¸í À§Çù »ç°Ç
  = Near Miss
  ; È£Èí Á¤Áö¿Í ºó¸Æ, û»ö...
ACE acetonitrile; acetylcholine esterase; acute cerebral encephalopathy; acute coronary event; adrenocor...
ADE acute disseminated encephalitis; adverse drug event; antibody-dependent enhancement; apparent digest...
AE above-elbow [amputation]; acrodermatitis enteropathica; activation energy; adult erythrocyte; advers...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
C 48/80 Compound 48/80
CAP Compound Action Potential
CMAP Compound motor action potential
CMAP Compound muscle action potential
CNAP Compound nerve action potential
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adverse event
    À¯ÇØ »ç·Ê
  • doping : the action of administering a drug to someone before a sports event
    originally to a horse before a race
    ; the substance thus administered.
  • perceptual event
    Áö°¢ »ç°Ç
  • precipitating event
    ÃËÁø »ç°Ç, ħ°­ »ç°Ç
  • addition compound
    ÷°¡ È­ÇÕ¹°
    µÎ °³ ÀÌ»óÀÇ È­ÇÕ¹°, ȤÀº ¿ø¼ÒÀÇ °áÇÕ¿¡ ÀÇÇØ¼­ »ý±ä È­ÇÕ¹°.
  • adsorption compound
    ÈíÂø È­ÇÕ¹°
  • antimuscarinic compound
    Ç×¹«½ºÄ«¸°Á¦
  • aromatic compound
    ¹æÇâÁ· È­ÇÕ¹°
  • chain compound
    »ç½½ È­ÇÕ¹°
  • compound action potential
    º¹ÇÕ È°µ¿ Àü¾Ð
  • compound anchorage
    º¹ÇÕ °íÁ¤
    µÎ °³ ȤÀº ±× ÀÌ»óÀÇ Ä¡¾Æ·ÎºÎÅÍ ÀúÇ×À» ¹Þ´Â ±³Á¤ °íÁ¤.
  • compound cavity
    º¹ÇÕ ¿Íµ¿
    óġµÈ »óÅ¿¡¼­ Ä¡¾ÆÀÇ 2¸éÀÌ Ä§½ÀµÈ ¿ì½Ä º´¼Ò.
  • compound composite odontoma
    º¹ÇÕ¼º Ä¡¾ÆÁ¾, ÁýÇÕ¼º Ä¡¾ÆÁ¾
  • compound dislocation
    º¹Àâ Å»±¸
  • compound gland
    º¹ÇÕ »ù, º¹ÇÕ¼±
    ºÐºñ °üÀÌ °¡Áö¸¦ ³½´Ù. ºÐºñ ´ÜÀ§´Â È¥ÇÕÇüÀ¸·Î, °ü»ó Æ÷»ó »ùÀ̶ó´Â ¿ë¾î°¡ »ç¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adverse event A toxic reaction to a medical therapy.
(09 Oct 1997)
vertical displacement event Disruption which occurs because plasma is not adequately stabilised against vertical motions.
(09 Oct 1997)
event, adverse In pharmacology, an adverse event is any unexpected or dangerous reaction to a drug.
(12 Dec 1998)
event-related potentials, p300 A late-appearing component of the event-related potential. P stands for positive voltage potential and 300 represents 300 millisecond poststimulus. Its amplitude increases with unpredictable, unlikely, or highly significant stimuli and thereby constitutes an index of mental activity.
(12 Dec 1998)
acetone compound <biochemistry> Any of the three compounds created by acetyl coenzyme A (acetoacetate, hydroxybutyrate, and acetone) which are water-soluble cellular fuels normally exported by the liver.
They can build up in the blood and body tissues because of starvation, untreated diabetes mellitus, or other disorders that interfere with carbohydrate metabolism. The body rids itself of ketones mainly through urine, but it rids itself of acetone through the lungs, which gives the breath a characteristic fruity odour. If ketones build up in the body long enough, they cause serious illness and coma (see ketoacidosis.)
(09 Oct 1997)
acyclic compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
addition compound Strictly, a complex of two or more complete molecules in which each preserves its fundamental structure and no covalent bonds are made or broken (e.g., hydrates of salts, adducts), loosely, association of acids with basic organic compound's (e.g., amines with HCl), more loosely, addition of two molecules without loss of any atom, but forming new covalent bonds (e.g., CH2==CH2 + Br2 &rarr; BrCH2-CH2Br).
(05 Mar 2000)
aliphatic compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
APC compound An analgesic tablet drug combination containing aspirin, phenacetin and caffeine. Very widely used in the 1940's through 1960's; original constituents of popular over-the-counter pain remedies. Use currently much diminished due to concerns about potential renal injury due to the phenacetin.
(05 Mar 2000)
aromatic compound Any compound in which the constituent atoms, or any part of them, form a ring. Used mainly in organic chemistry where: 1) numerous compound's contain rings of carbon atoms (carbocyclic compound's) or carbon atoms plus one or more atoms of other types (heterocyclic compound's), usually nitrogen, oxygen, or sulfur; 2) where the atoms in the ring are all of the same element (homocyclic or isocyclic compound); 3) where the ring is saturated or contains nonconjugated double bonds (alicyclic compound), the compound is similar in properties to the corresponding acyclic compound (e.g., cyclohexane resembles hexane); 4) where the ring contains conjugated double bonds in a closed loop in which there are 4n + 2 (where n is an integer) delocalised &pi; electrons (Huckel's rule) (aromatic compound; e.g., benzene, pyridine), it is more stable than the corresponding saturated ring and exhibits unusual chemical properties characteristic of itself and not of other types of rings or of acyclic compound's. These aromatic compounds have the ability to sustain an induced ring current.
Synonym: closed chain compound, ring compound.
(05 Mar 2000)
binary compound <chemistry> This refers to any compound that is composed of only two elements.
(09 Oct 1997)
calcium compound Inorganic compounds that contain calcium as an integral part of the molecule.
(12 Dec 1998)
carbamino compound Any carbamic acid derivative formed by the combination of carbon dioxide with a free amino group to form an N-carboxy group, -NH-COOH, as in haemoglobin forming carbaminohemoglobin.
(05 Mar 2000)
carbocyclic compound See: cyclic compound.
(05 Mar 2000)
genetic compound In medical genetics, the presence of two different mutant alleles at the same loci.
Synonym: genetic compound.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • event
    »ç°Ç,°á°ú
  • event
    »ç°Ç;Å« »ç°Ç;°æ°ú;°á°ú;°æ¿ì;Á¾¸ñ;½ÃÇÕ(at all events Á¿찣,ÇÏ¿©Æ°,in any event ¹«½¼ ÀÏÀÌ À־,ÇÏ¿©Æ°)
  • field event
    ÇÊµå °æ±â
  • happy event
    °æ»ç;(ƯÈ÷)Ãâ»ê;ź»ý 9
  • main event
    ÁÖ¿ä °æ±â
  • media event
    (¸Å½ºÄÄ º¸µµ¸¦ ¿¹»óÇÏ¿©) Â¥¿©Áø »ç°Ç(Çà»ç);(¸Å½ºÄÄ¿¡ È®´ë(°ú´ë) º¸µµµÈ);Á¶ÀÛµÈ Å« »ç°Ç
  • compound
    À» ÇÕ¼ºÇÏ´Ù
  • compound
    ÇÕ¼ºÀÇ;È¥¼ºÀÇ;º¹ÇÕÀÇ;º¹ÀâÇÑ;º¹½ÄÀÇ;È­ÇÕÇÑ;ÁýÇÕÀÇ;(¹®ÀåÀÌ)Áß¹®ÀÇ;(³¹¸»ÀÌ)º¹ÇÕÀÇ;(ÀúÅÃ.°øÀåÀÇ)¿ï¾È;±¸³»;È¥ÇÕ¹°;ÇÕ¼º¹°;È­ÇÕ¹°;º¹ÇÕ¾î;ÇÕ¼º¾î;(¿ä¼Ò.¼ººÐµîÀ»)È¥ÇÕÇÏ´Ù;ÇÕ¼ºÇÏ´Ù;(¾à µîÀ»)Á¶Á¦ÇÏ´Ù;¼¯¾î¼­ ¸¸µé´Ù;(ÀÏÀ»)È­ÇØ½ÃŰ´Ù;À̾߱â·Î ÇØ°áÁþ´Ù;»çÈ­ÇÏ°Ô ÇÏ´Ù;(°è
  • compound E
    º¹ÇÕ E¹°Áú
  • compound engine
    º¹½Ä ±â°ü;2´Ü ÆØÃ¢±â°ü
  • compound eye
    º¹¾È;°ã´«
  • compound flower
    µÎ»óÈ­;°ã²É(±¹È­°ú ½Ä¹°µîÀÇ)
  • compound fraction
    COMPLEX FRACTION
  • compound fracture
    °³¹æ °ñÀý
  • compound fruit
    °ã¿­¸Å;º¹°ú 
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á